Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases
SEC Filings
| Document Date | Form | Description | Filing Group | View |
|---|---|---|---|---|
| 10-Q |
Quarterly report which provides a continuing view of a company's financial position |
Quarterly Filings
|
||
| DEF 14A |
Official notification to shareholders of matters to be brought to a vote ("Proxy") |
Proxy Filings
|
||
| DEFA14A |
Additional proxy soliciting materials - definitive |
Proxy Filings
|
||
| ARS |
An annual report to security holders |
Annual Filings
|
||
| EFFECT |
EFFECT |
Other
|
||
| 3 |
Initial filing by director officer or owner of more than ten percent. |
3,4,5
|
||
| CORRESP |
CORRESP |
Other
|
||
| UPLOAD |
UPLOAD |
Other
|
||
| 10-K |
Annual report which provides a comprehensive overview of the company for the past year |
Annual Filings
|
||
| S-8 |
Securities offered to employees pursuant to employee benefit plans |
Registration Statements
|
Displaying 1 - 10 of 309 results
Data provided by Kaleidoscope.